bioshares recommended to buy tis, page-16

Here are my thoughts on commercial deal:

1. The annual general meeting is scheduled for Mon 28 November 2011. Our management is very confident now, so it is likely that the deal will be announced at least 1 week before 28/11, say 14/11 to 24/11.

2. Management told me in previous correspondence that the partner wants a margin of around 70%, so royalty to TIS is around 30%.

3. Because Dr Mercer has used the word PARTNER (NOT partnerS) many times recently, I think that we will have the deal with an exclusive world wide partner. Who?

If I were the management, I would choose a partner which is NOT ONLY large enough for global sales BUT ALSO gives the company full attention and care. So, Smith&Nephew or J&J might not be the suitable candidate. Time will tell whether my thoughts are true or not.

My opinions only. Please DYOR.